🦋Shensi Shen 慎思🦩
@seansi.bsky.social
Our lab is interested in cancer cell plasticity, special focus on drug tolerant persisters 🦋 Group leader at WCH 🇫🇷🇨🇳🇺🇦🏳️🌈 equality in science 🧏🏻♂️
https://www.ssshen.com
https://www.ssshen.com
⏰ Last chance to submit your abstract for Signalling Circuits in Cancer!
Don’t miss your opportunity to be part of this exciting new conference topic. If your work explores oncogenic signalling, cellular communication networks, this is the perfect platform to showcase your research.
Don’t miss your opportunity to be part of this exciting new conference topic. If your work explores oncogenic signalling, cellular communication networks, this is the perfect platform to showcase your research.
There's not long left for you to submit your abstract for Signalling Circuits in Cancer!
If your research falls into any of these categories, don't miss your opportunity to be included in this new conference topic.
eacr.org/conference/s...
If your research falls into any of these categories, don't miss your opportunity to be included in this new conference topic.
eacr.org/conference/s...
November 28, 2025 at 8:59 PM
⏰ Last chance to submit your abstract for Signalling Circuits in Cancer!
Don’t miss your opportunity to be part of this exciting new conference topic. If your work explores oncogenic signalling, cellular communication networks, this is the perfect platform to showcase your research.
Don’t miss your opportunity to be part of this exciting new conference topic. If your work explores oncogenic signalling, cellular communication networks, this is the perfect platform to showcase your research.
Glad to share our latest perspective published on @natcomms.nature.com, trying to push #DTP research to a new frontier. Thanks to very helpful and constructive suggestions from the reviewers and editors!
Drug-tolerant persisters #DTP, a rare subpopulation of cancer cells, can survive therapy via reversible non-genetic mechanisms. @seansi.bsky.social lab provide their #perspective on the gaps and research paths still needed to bridge basic DTP research with the clinic. www.nature.com/articles/s41...
November 19, 2025 at 3:28 PM
Glad to share our latest perspective published on @natcomms.nature.com, trying to push #DTP research to a new frontier. Thanks to very helpful and constructive suggestions from the reviewers and editors!
Our journal @oncogenesisnature.bsky.social is officially on Bluesky, follow us to know more about frontier oncological advances
📣 Welcome to the official Bluesky page of Oncogenesis!
Oncogenesis is an open-access journal focused on the molecular basis of cancer and tumor development.
Follow us to know more!
🔗 oncogenesisjournal.nature.com
#CancerResearch #NaturePortfolio #Oncogenesis
Oncogenesis is an open-access journal focused on the molecular basis of cancer and tumor development.
Follow us to know more!
🔗 oncogenesisjournal.nature.com
#CancerResearch #NaturePortfolio #Oncogenesis
oncogenesisjournal.nature.com
May 12, 2025 at 2:12 AM
Our journal @oncogenesisnature.bsky.social is officially on Bluesky, follow us to know more about frontier oncological advances
Reposted by 🦋Shensi Shen 慎思🦩
One month left to register for the 2025 Early Career Researchers Conference!
In its fifth edition, this virtual conference has become a must-attend for early career researchers to discuss critical aspects of a scientific career in cancer research.
Don't miss it: eacr.org/conference/e...
In its fifth edition, this virtual conference has become a must-attend for early career researchers to discuss critical aspects of a scientific career in cancer research.
Don't miss it: eacr.org/conference/e...
May 9, 2025 at 8:01 AM
One month left to register for the 2025 Early Career Researchers Conference!
In its fifth edition, this virtual conference has become a must-attend for early career researchers to discuss critical aspects of a scientific career in cancer research.
Don't miss it: eacr.org/conference/e...
In its fifth edition, this virtual conference has become a must-attend for early career researchers to discuss critical aspects of a scientific career in cancer research.
Don't miss it: eacr.org/conference/e...
Join this fzntastic meeting in beautiful Lisboa @helloeacr.bsky.social
Joining us in Lisbon this summer for #EACR2025? Why not take time to explore this beautiful city while you’re here!
Some of our Lisbon-based EACR Ambassadors have shared their local knowledge and insights into what makes Lisbon a great place to visit: 2025.eacr.org/explore-lisbon
Some of our Lisbon-based EACR Ambassadors have shared their local knowledge and insights into what makes Lisbon a great place to visit: 2025.eacr.org/explore-lisbon
March 11, 2025 at 12:44 AM
Join this fzntastic meeting in beautiful Lisboa @helloeacr.bsky.social
Reposted by 🦋Shensi Shen 慎思🦩
The EACR stands against threats to cancer research. Protecting scientific research is vital for progress and and the development of new treatments. Read our full statement in support of our friends and colleagues in the US: eacr.org/statement-on...
March 10, 2025 at 12:02 PM
The EACR stands against threats to cancer research. Protecting scientific research is vital for progress and and the development of new treatments. Read our full statement in support of our friends and colleagues in the US: eacr.org/statement-on...
Reposted by 🦋Shensi Shen 慎思🦩
EACR members, you're invited to join us for an in-depth discussion on securing cancer research funding!
Chat with our expert guest speakers about funding opportunities, grant writing, interview strategies and more in this interactive workshop.
📅 10 March 12:00 CET
us02web.zoom.us/meeting/regi...
Chat with our expert guest speakers about funding opportunities, grant writing, interview strategies and more in this interactive workshop.
📅 10 March 12:00 CET
us02web.zoom.us/meeting/regi...
March 5, 2025 at 10:04 AM
EACR members, you're invited to join us for an in-depth discussion on securing cancer research funding!
Chat with our expert guest speakers about funding opportunities, grant writing, interview strategies and more in this interactive workshop.
📅 10 March 12:00 CET
us02web.zoom.us/meeting/regi...
Chat with our expert guest speakers about funding opportunities, grant writing, interview strategies and more in this interactive workshop.
📅 10 March 12:00 CET
us02web.zoom.us/meeting/regi...
Highly recommend this nice work published on Cancer Discovery that we are honored to write a View in the context of EMT @theaacr.bsky.social
March 5, 2025 at 12:35 AM
Highly recommend this nice work published on Cancer Discovery that we are honored to write a View in the context of EMT @theaacr.bsky.social
It is not Nash’s game theory . Defense -attack, we do not want zero-sum game, we wanna the best attack by defense. Join this wonderful meeting in Barcelona with @helloeacr.bsky.social
There's a month left for you to submit an abstract or apply for a Travel Grant to attend the next edition of Defence is the Best Attack, taking place in Barcelona in May! ☀️
Join us for an overview of the most recent advances in the field of immunotherapy:
eacr.org/conference/d...
Join us for an overview of the most recent advances in the field of immunotherapy:
eacr.org/conference/d...
March 1, 2025 at 1:25 AM
It is not Nash’s game theory . Defense -attack, we do not want zero-sum game, we wanna the best attack by defense. Join this wonderful meeting in Barcelona with @helloeacr.bsky.social
Wanna meet experts in drug tolerant persister cells? Learn more about the frontiers of cancer cell plasticity and minimal residual diseases, come to join us in Lyon France for this @helloeacr.bsky.social EACR conference!
Registration for Persister Cells: from Bacteria to Cancer closes on 17 February!
Don't miss the chance to join us in beautiful Lyon as we delve into molecular mechanisms, therapeutic targets and emerging clinical implications of cancer persister cells.
eacr.org/conference/p...
Don't miss the chance to join us in beautiful Lyon as we delve into molecular mechanisms, therapeutic targets and emerging clinical implications of cancer persister cells.
eacr.org/conference/p...
February 7, 2025 at 4:12 PM
Wanna meet experts in drug tolerant persister cells? Learn more about the frontiers of cancer cell plasticity and minimal residual diseases, come to join us in Lyon France for this @helloeacr.bsky.social EACR conference!
In the year of Snake 🐍 2025, join us @helloeacr.bsky.social in beautiful Lisboa for a prosperous year of EACR congress!
Register to join us for the #EACR2025 Congress!
Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 28 April.
We can't wait to welcome you and the wider cancer research community in Lisbon!
2025.eacr.org
Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 28 April.
We can't wait to welcome you and the wider cancer research community in Lisbon!
2025.eacr.org
January 31, 2025 at 9:56 AM
In the year of Snake 🐍 2025, join us @helloeacr.bsky.social in beautiful Lisboa for a prosperous year of EACR congress!
MIF is the devil 😈 in detail of low intra-tumoral heterogeneous cancer that evade immune surveillances.
aacrjournals.org/cancerdiscov...
aacrjournals.org/cancerdiscov...
December 8, 2024 at 2:37 PM
MIF is the devil 😈 in detail of low intra-tumoral heterogeneous cancer that evade immune surveillances.
aacrjournals.org/cancerdiscov...
aacrjournals.org/cancerdiscov...
It was a fun to bring together reflections from researchers across various fields on inspiring cancer studies in 2024
What were the most inspiring 2024 discoveries in cancer?
Cancer Discovery asked me, Katherine Aird, Aadel Chaudhuri, Jennifer Guerriero, Shiri Gur-Cohen, Benjamin Izar, Brittany Jenkins, Delphine Merino, Alejo Rodriguez-Fraticelli & Shensi Shen, & here's what we said
aacrjournals.org/cancerdiscov...
Cancer Discovery asked me, Katherine Aird, Aadel Chaudhuri, Jennifer Guerriero, Shiri Gur-Cohen, Benjamin Izar, Brittany Jenkins, Delphine Merino, Alejo Rodriguez-Fraticelli & Shensi Shen, & here's what we said
aacrjournals.org/cancerdiscov...
December 4, 2024 at 1:28 AM
It was a fun to bring together reflections from researchers across various fields on inspiring cancer studies in 2024
The waltz between metabolism and mRNA translation. Find out our new insight on this interaction between two essential cellular adaptive responses to stresses.
authors.elsevier.com/c/1kAJt3QxxS...
authors.elsevier.com/c/1kAJt3QxxS...
November 27, 2024 at 4:37 PM
The waltz between metabolism and mRNA translation. Find out our new insight on this interaction between two essential cellular adaptive responses to stresses.
authors.elsevier.com/c/1kAJt3QxxS...
authors.elsevier.com/c/1kAJt3QxxS...
Life is short, Carpe Diem by ribosomes 🙆
@cellpress.bsky.social #ribosomes
www.cell.com/cell/fulltex...
@cellpress.bsky.social #ribosomes
www.cell.com/cell/fulltex...
The ribosome comes to life
The ribosome is an ancient molecular machine that coverts the genetic information
carried by mRNA into protein, a crucial step in linking genotype to phenotype. This
review discusses landmark advances...
www.cell.com
November 27, 2024 at 1:13 AM
Life is short, Carpe Diem by ribosomes 🙆
@cellpress.bsky.social #ribosomes
www.cell.com/cell/fulltex...
@cellpress.bsky.social #ribosomes
www.cell.com/cell/fulltex...
Reposted by 🦋Shensi Shen 慎思🦩
The AACR Cancer Progress Report 2024 highlights research-driven advances in cancer science and medicine. Read the Report: CancerProgressReport.org
#CancerProgressReport
#CancerProgressReport
November 25, 2024 at 7:15 PM
The AACR Cancer Progress Report 2024 highlights research-driven advances in cancer science and medicine. Read the Report: CancerProgressReport.org
#CancerProgressReport
#CancerProgressReport
Reposted by 🦋Shensi Shen 慎思🦩
Did you catch our latest podcast episode? 🎧
Tune in for an insightful conversation with the authors of a recent Nature Cancer article on a novel pan-lysyl oxidase inhibitor in #PancreaticCancer.
magazine.eacr.org/a-novel-pan-...
Tune in for an insightful conversation with the authors of a recent Nature Cancer article on a novel pan-lysyl oxidase inhibitor in #PancreaticCancer.
magazine.eacr.org/a-novel-pan-...
November 20, 2024 at 12:31 PM
Did you catch our latest podcast episode? 🎧
Tune in for an insightful conversation with the authors of a recent Nature Cancer article on a novel pan-lysyl oxidase inhibitor in #PancreaticCancer.
magazine.eacr.org/a-novel-pan-...
Tune in for an insightful conversation with the authors of a recent Nature Cancer article on a novel pan-lysyl oxidase inhibitor in #PancreaticCancer.
magazine.eacr.org/a-novel-pan-...
Join us at the EACR-Boehringer Ingelheim virtual conference @EACR on Drugging and Regulating the MAP Kinase Pathway (11-12 February 2025) where we will assess the basic and clinical aspects of the regulation of signaling through the MAPK pathway and its role in cancer.
eacr.org/conference/b...
eacr.org/conference/b...
November 18, 2024 at 11:18 PM
Join us at the EACR-Boehringer Ingelheim virtual conference @EACR on Drugging and Regulating the MAP Kinase Pathway (11-12 February 2025) where we will assess the basic and clinical aspects of the regulation of signaling through the MAPK pathway and its role in cancer.
eacr.org/conference/b...
eacr.org/conference/b...
Ribosomes are heterogenous and long believed immunoribosome revealed by this study that P-Stalk ribosome responds to inflammatory cues and alert 🚨 cell immune response.
www.cell.com/cell/fulltex...
www.cell.com/cell/fulltex...
P-stalk ribosomes act as master regulators of cytokine-mediated processes
Cytokines remodel the ribosome to incorporate the P-stalk, therefore altering the
translation of mRNAs involved in cytokine responses.
www.cell.com
November 18, 2024 at 5:14 AM
Ribosomes are heterogenous and long believed immunoribosome revealed by this study that P-Stalk ribosome responds to inflammatory cues and alert 🚨 cell immune response.
www.cell.com/cell/fulltex...
www.cell.com/cell/fulltex...
Reposted by 🦋Shensi Shen 慎思🦩
Too often we spend only two weeks choosing a problem and then many years trying solving it, but this limits our potential impact.
A must read for PhD students: Problem choice and decision trees in science and engineering.
pubmed.ncbi.nlm.nih.gov/38608651/
A must read for PhD students: Problem choice and decision trees in science and engineering.
pubmed.ncbi.nlm.nih.gov/38608651/
November 17, 2024 at 5:35 PM
Too often we spend only two weeks choosing a problem and then many years trying solving it, but this limits our potential impact.
A must read for PhD students: Problem choice and decision trees in science and engineering.
pubmed.ncbi.nlm.nih.gov/38608651/
A must read for PhD students: Problem choice and decision trees in science and engineering.
pubmed.ncbi.nlm.nih.gov/38608651/
November 17, 2024 at 1:51 PM
Shifting from X to BlueSky, first tweet 🐣 maybe our recent roadmap will let you know better what we are working on in the lab 🧫 link: www.nature.com/articles/s41...
November 17, 2024 at 1:42 PM
Shifting from X to BlueSky, first tweet 🐣 maybe our recent roadmap will let you know better what we are working on in the lab 🧫 link: www.nature.com/articles/s41...